CRIS Current Research Information System

MANZOLI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.296
EU - Europa 7.225
AS - Asia 6.611
AF - Africa 681
SA - Sud America 444
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 23.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.204
SG - Singapore 2.232
IT - Italia 2.127
CN - Cina 1.948
GB - Regno Unito 1.230
DE - Germania 967
SE - Svezia 916
VN - Vietnam 897
HK - Hong Kong 512
RU - Federazione Russa 321
BR - Brasile 319
IN - India 308
NL - Olanda 281
KR - Corea 279
FR - Francia 238
UA - Ucraina 199
IE - Irlanda 196
TG - Togo 194
SC - Seychelles 161
JP - Giappone 151
CI - Costa d'Avorio 139
FI - Finlandia 129
ZA - Sudafrica 97
AT - Austria 89
CH - Svizzera 88
EE - Estonia 88
BG - Bulgaria 87
HR - Croazia 83
NG - Nigeria 67
JO - Giordania 63
AR - Argentina 61
CA - Canada 61
BE - Belgio 59
ID - Indonesia 50
PL - Polonia 30
ES - Italia 29
TR - Turchia 26
BD - Bangladesh 19
IR - Iran 19
RO - Romania 19
EC - Ecuador 18
MX - Messico 17
PK - Pakistan 17
CO - Colombia 15
AU - Australia 14
LT - Lituania 13
UZ - Uzbekistan 13
GR - Grecia 11
MY - Malesia 10
UY - Uruguay 10
IL - Israele 9
TH - Thailandia 9
CL - Cile 8
LB - Libano 8
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
MA - Marocco 6
NZ - Nuova Zelanda 6
EG - Egitto 5
PY - Paraguay 5
TN - Tunisia 5
KZ - Kazakistan 4
PH - Filippine 4
VE - Venezuela 4
AZ - Azerbaigian 3
BZ - Belize 3
DK - Danimarca 3
HU - Ungheria 3
AL - Albania 2
AM - Armenia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
KG - Kirghizistan 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SS - ???statistics.table.value.countryCode.SS??? 2
SV - El Salvador 2
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
Totale 23.270
Salva come PNG Salva come JPEG
Città #
Singapore 1.498
Southend 1.019
Ashburn 959
Chandler 806
Fairfield 712
Bologna 690
Santa Clara 516
Hong Kong 505
Hefei 489
Ann Arbor 415
Houston 407
Woodbridge 317
Wilmington 290
Dallas 277
Beijing 267
Princeton 267
Seattle 257
Dong Ket 251
Boardman 240
Cambridge 229
Dublin 195
Lomé 194
Seoul 193
Milan 164
Ho Chi Minh City 162
Hanoi 142
Frankfurt am Main 141
Abidjan 139
Nanjing 115
Padova 115
Westminster 108
Tokyo 107
Jacksonville 106
New York 101
Berlin 91
Los Angeles 91
Sofia 87
Buffalo 72
Helsinki 70
Bern 69
Munich 68
Turin 66
Abeokuta 64
Jinan 64
San Diego 64
Vienna 63
Amman 62
Redondo Beach 57
Redwood City 56
Saint Petersburg 55
Brussels 54
Rome 48
Redmond 46
Medford 44
Shenyang 43
Florence 42
Changsha 41
Bengaluru 40
Moscow 39
Udine 38
Bremen 37
London 35
Jakarta 32
Nanchang 32
São Paulo 32
Turku 32
Guangzhou 31
Shanghai 29
Chicago 28
Falkenstein 27
Hebei 27
Lappeenranta 27
Parma 27
Amsterdam 25
Falls Church 25
Nuremberg 25
Castel Maggiore 24
Des Moines 24
Haiphong 24
Toronto 23
Dearborn 22
Tappahannock 22
Tianjin 21
Mülheim 20
Verona 20
Yubileyny 20
Norwalk 19
Reggio Emilia 19
San Francisco 19
Düsseldorf 18
Jiaxing 18
Sejong 18
Warsaw 18
Forlì 17
Boston 16
Modena 16
Mountain View 16
Phoenix 16
Stockholm 16
Biên Hòa 15
Totale 14.859
Salva come PNG Salva come JPEG
Nome #
Multiple roles of phosphoinositide-specific phospholipase C isozymes. 327
AEducaAR, Anatomical Education in Augmented Reality: A Pilot Experience of an Innovative Educational Tool Combining AR Technology and 3D Printing 305
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 304
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients 236
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response 234
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 231
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 216
Near-peer teaching in human anatomy from a tutors’ perspective: An eighteen-year-old experience at the university of Bologna 212
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes 211
Inositide-Dependent Nuclear Signalling in Health and Disease 210
In vitro reparative dentin: a biochemical and morphological study. 208
Anatomic Cartography of the Hypogastric Nerves and Surgical Insights for Autonomic Preservation during Radical Pelvic Procedures. 207
Endoscopic endonasal anatomy of the ophthalmic artery in the optic canal 206
Anatomy of the optic canal and its clinical role 202
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 200
Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2 197
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes 197
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide 196
Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna 194
Nuclear inositide signaling and cell cycle 194
Augmented Reality-Assisted Periosteum Pedicled Flap Harvesting for Head and Neck Reconstruction: An Anatomical and Clinical Viability Study of a Galeo-Pericranial Flap 193
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS 189
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 189
Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy 189
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES 187
Anatomical Laser Microdissection of the Ileum Reveals mtDNA Depletion Recovery in A Mitochondrial Neuro-Gastrointestinal Encephalomyopathy (MNGIE) Patient Receiving Liver Transplant 185
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes 184
A scientific (c)old case at “Luigi Cattaneo” Anatomical Wax Collection in Bologna: solving an intriguing puzzle? 184
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 181
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS 181
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 181
Combining prelamin A accumulation and oxidative stress: A strategy to target glioblastoma 177
Nuclear inositides: facts and perspectives. 175
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 175
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside 174
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 174
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 174
Inositide signaling in the nucleus: From physiology to pathology. 173
Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia 173
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients 172
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 171
Endoscopic endonasal approach to primitive Meckel's cave tumors: a clinical series 171
Nuclear Inositide Signaling via Phospholipase C 171
Anatomical variations of the right renal and spermatic arteries: a case report 170
Regulation of nuclear phospholipase C activity 167
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 167
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia 166
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 165
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 163
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 162
To the Heart of IFs Function: Do they Aggregate on Purpose? 161
Nuclear phospholipase C beta1 and cellular differentiation. 160
PLA-Based Mineral-Doped Scaffolds Seeded with Human Periapical Cyst-Derived MSCs: A Promising Tool for Regenerative Healing in Dentistry 160
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 158
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 158
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression 158
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 156
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 156
Dissecting human anatomy learning process through anatomical education with augmented reality: AEducAR 2.0, an updated interdisciplinary study 154
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 153
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 153
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES 152
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 152
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 152
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 151
The whole body donation program at the university of Bologna: A report based on the experience of one of the oldest university in Western world 150
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway 149
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 149
Structural Variants at the LMNB1 Locus: Deciphering Pathomechanisms in Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 148
Hepato-gastric and spleno-mesenteric arterial trunks: anatomical variation report and review of literature 148
PLC and PI3K/Akt/mTOR signalling in disease and cancer 147
Three-dimensional virtual anatomy as a new approach for medical student’s learning 147
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 146
Significance of subnuclear licalization of key players of inositol lipid cycle. 145
null 144
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients 144
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes 143
Advances in MDS/AML and inositide signalling 142
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 142
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 142
Modulation of nuclear PI-PLCbeta1 during cell differentiation 140
Nuclear Nox4-Derived Reactive Oxygen Species in Myelodysplastic Syndromes 140
Investigation of human cadavers: one year of anatomic variants and their clinical correlation 140
Nuclear inositide signaling in myelodysplastic syndromes. 139
Unilateral absence of Casserio’s nerve and a communicating branch to the median nerve. An additional variant of brachial flexors motor innervation 139
Lamin B1 as a key modulator of the developing and aging brain 138
Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy 138
Exploring the controversial role of PI3K signalling in CD4+ regulatory T (T-Reg) cells 138
The variants of the retro- and hypotympanum: an endoscopic anatomical study 137
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment 136
The anatomy of the pelvic plexus in female cadavers: implications for retroperitoneal nerve-sparing surgery 135
Metabolism and signaling activities of nuclear lipids 134
Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia. 133
Nuclear PI-PLCbeta1-Lamin B1 complex signalling during cell cycle progression in human erytholeukemia cells 133
Nuclear diacylglycerol kinase-{zeta} is a negative regulator of cell cycle progression in C2C12 mouse myoblasts 133
Augmented Reality in Higher Education an Exploratory Study on the Beliefs of Medical Students 132
The Circle of Willis: a review and a case report 132
Hypo and retrotympanum: the importance of anatomical variants 132
PI-PLCβ1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro-B-lymphoblastic cells exposed to oxidative stress 132
Recent advances in MDS mutation landscape: Splicing and signalling 132
Totale 17.003
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.252 0 0 0 0 0 118 94 136 157 97 98 552
2021/20223.050 221 56 175 284 241 144 133 187 106 503 530 470
2022/20233.544 341 450 178 523 303 266 223 220 536 62 212 230
2023/20241.464 96 197 139 145 152 207 68 81 100 131 64 84
2024/20254.553 167 527 363 299 672 253 405 201 106 361 316 883
2025/20265.401 904 1.208 1.072 763 1.185 269 0 0 0 0 0 0
Totale 23.880